These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 1687945

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 5. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 6. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 7. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Oct; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.
    Kobayashi S, Ogren SO, Hoffer BJ, Olson L.
    Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169
    [Abstract] [Full Text] [Related]

  • 10. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN.
    Brain Res; 2008 Mar 10; 1198():44-54. PubMed ID: 18261716
    [Abstract] [Full Text] [Related]

  • 11. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
    Uchida T, Lee J, Fujita S, Kiguchi M, Matsumoto M, Oi Y, Gionhaku N, Koshikawa N.
    Methods Find Exp Clin Pharmacol; 2005 Mar 10; 27(1):31-7. PubMed ID: 15834457
    [Abstract] [Full Text] [Related]

  • 12. Behavioral differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats with normosensitive DA receptors.
    Arnt J, Hyttel J.
    Pharmacopsychiatry; 1988 Jan 10; 21(1):24-7. PubMed ID: 2966410
    [Abstract] [Full Text] [Related]

  • 13. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS, Joyce JN.
    Synapse; 1992 May 10; 11(1):35-46. PubMed ID: 1351321
    [Abstract] [Full Text] [Related]

  • 14. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis.
    Nisoli E, Tonello C, Memo M, Carruba MO.
    J Pharmacol Exp Ther; 1992 Nov 10; 263(2):823-9. PubMed ID: 1359119
    [Abstract] [Full Text] [Related]

  • 15. Prenatal ethanol preferentially enhances reactivity of the dopamine D1 but not D2 or D3 receptors in offspring.
    Sobrian SK, Jones BL, James H, Kamara FN, Holson RR.
    Neurotoxicol Teratol; 2005 Nov 10; 27(1):73-93. PubMed ID: 15681123
    [Abstract] [Full Text] [Related]

  • 16. Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease: sites of action and implications for the pathogenesis of dyskinesias.
    Robertson HA.
    Can J Neurol Sci; 1992 Feb 10; 19(1 Suppl):147-52. PubMed ID: 1349263
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.
    Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD.
    J Pharmacol Exp Ther; 2000 Aug 10; 294(2):680-7. PubMed ID: 10900248
    [Abstract] [Full Text] [Related]

  • 18. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE, Johnson KB, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1993 May 10; 265(2):1001-10. PubMed ID: 8098756
    [Abstract] [Full Text] [Related]

  • 19. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G, Zhou LW, Morabito M, Zhang SP, Weiss B.
    J Pharmacol Exp Ther; 1998 Jun 10; 285(3):1187-96. PubMed ID: 9618422
    [Abstract] [Full Text] [Related]

  • 20. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.
    Clark D, White FJ.
    Synapse; 1987 Jun 10; 1(4):347-88. PubMed ID: 2971273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.